Medcan, a global leader in proactive health and wellness, announced the Canadian launch of the Galleri® multi-cancer early detection (MCED) test by GRAIL-- now offered exclusively at Medcan's clinics.

Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data presented at IDWeek 2025tm in Atlanta, Ga., by researchers from Columbia University ...

研究结论表明，突尼斯人群IBC具有复杂且异质性的遗传背景，涉及DNA修复缺陷和炎症通路异常的双重机制。这种遗传多样性可能反映了突尼斯人群的混合祖先背景（柏柏尔人、阿拉伯人、安达卢西亚人等）。值得注意的是，大多数患者携带多个中高风险变异，支持了IBC遗传易感性的多基因模型。

The indolent lymphoma market is witnessing steady growth driven by the increasing prevalence of slow-growing non-Hodgkin ...

Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures biopharmaceuticals like vaccines are ...

In the forests of Finnish Lapland, beneath which some gold is known to lie underground, scientists have found something ...

As costs for diagnostic and sequencing technologies have plummeted in recent years, researchers have collected an unprecedented amount of data around ...

Key market opportunities in mutation detection kits for genome editing include addressing rising genetic disorders with ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 13, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Long‑Read Sequencing Services Market Through 2025? The market size for long-read ...

The Senate passed two major pieces of legislation this week targeting U.S. technology and security ties with China, limiting ...